vs
Orthofix Medical Inc.（OFIX）与通用动力（PLOW）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是通用动力的1.2倍（$219.9M vs $184.5M），通用动力净利率更高（7.0% vs -1.0%，领先8.0%），通用动力同比增速更快（28.6% vs 2.0%），通用动力自由现金流更多（$92.8M vs $16.8M），过去两年通用动力的营收复合增速更高（38.9% vs 8.0%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
通用动力公司是总部位于美国弗吉尼亚州雷斯顿的工业与科技企业，核心业务是研发制造各类先进军用装备，产品包括核潜艇、主战坦克、装甲战车等，同时也生产民用湾流公务机，并提供信息技术服务，是美国联邦政府前五大国防承包商之一。
OFIX vs PLOW — 直观对比
营收规模更大
OFIX
是对方的1.2倍
$184.5M
营收增速更快
PLOW
高出26.6%
2.0%
净利率更高
PLOW
高出8.0%
-1.0%
自由现金流更多
PLOW
多$76.0M
$16.8M
两年增速更快
PLOW
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $184.5M |
| 净利润 | $-2.2M | $12.8M |
| 毛利率 | 71.1% | 26.1% |
| 营业利润率 | 0.2% | 10.5% |
| 净利率 | -1.0% | 7.0% |
| 营收同比 | 2.0% | 28.6% |
| 净利润同比 | 92.4% | 62.3% |
| 每股收益（稀释后） | $-0.05 | $0.54 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXPLOW
| Q4 25 | $219.9M | $184.5M | ||
| Q3 25 | $205.6M | $162.1M | ||
| Q2 25 | $203.1M | $194.3M | ||
| Q1 25 | $193.6M | $115.1M | ||
| Q4 24 | $215.7M | $143.5M | ||
| Q3 24 | $196.6M | $129.4M | ||
| Q2 24 | $198.6M | $199.9M | ||
| Q1 24 | $188.6M | $95.7M |
净利润OFIXPLOW
| Q4 25 | $-2.2M | $12.8M | ||
| Q3 25 | $-22.8M | $8.0M | ||
| Q2 25 | $-14.1M | $26.0M | ||
| Q1 25 | $-53.1M | $148.0K | ||
| Q4 24 | $-29.1M | $7.9M | ||
| Q3 24 | $-27.4M | $32.3M | ||
| Q2 24 | $-33.4M | $24.3M | ||
| Q1 24 | $-36.0M | $-8.4M |
毛利率OFIXPLOW
| Q4 25 | 71.1% | 26.1% | ||
| Q3 25 | 72.2% | 23.5% | ||
| Q2 25 | 68.7% | 31.0% | ||
| Q1 25 | 62.8% | 24.5% | ||
| Q4 24 | 69.0% | 24.9% | ||
| Q3 24 | 68.7% | 23.9% | ||
| Q2 24 | 67.8% | 30.7% | ||
| Q1 24 | 67.5% | 19.8% |
营业利润率OFIXPLOW
| Q4 25 | 0.2% | 10.5% | ||
| Q3 25 | -8.3% | 8.7% | ||
| Q2 25 | -7.9% | 19.0% | ||
| Q1 25 | -25.2% | 2.8% | ||
| Q4 24 | -5.3% | 9.0% | ||
| Q3 24 | -9.6% | 35.4% | ||
| Q2 24 | -12.5% | 18.2% | ||
| Q1 24 | -15.6% | -6.7% |
净利率OFIXPLOW
| Q4 25 | -1.0% | 7.0% | ||
| Q3 25 | -11.1% | 4.9% | ||
| Q2 25 | -6.9% | 13.4% | ||
| Q1 25 | -27.4% | 0.1% | ||
| Q4 24 | -13.5% | 5.5% | ||
| Q3 24 | -13.9% | 24.9% | ||
| Q2 24 | -16.8% | 12.2% | ||
| Q1 24 | -19.1% | -8.7% |
每股收益（稀释后）OFIXPLOW
| Q4 25 | $-0.05 | $0.54 | ||
| Q3 25 | $-0.57 | $0.33 | ||
| Q2 25 | $-0.36 | $1.09 | ||
| Q1 25 | $-1.35 | $0.00 | ||
| Q4 24 | $-0.76 | $0.35 | ||
| Q3 24 | $-0.71 | $1.36 | ||
| Q2 24 | $-0.88 | $1.02 | ||
| Q1 24 | $-0.95 | $-0.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | — |
| 总债务越低越好 | — | $144.0M |
| 股东权益账面价值 | $450.0M | $281.4M |
| 总资产 | $850.6M | $626.7M |
| 负债/权益比越低杠杆越低 | — | 0.51× |
8季度趋势，按日历期对齐
现金及短期投资OFIXPLOW
| Q4 25 | $82.0M | — | ||
| Q3 25 | $62.9M | — | ||
| Q2 25 | $65.6M | — | ||
| Q1 25 | $58.0M | — | ||
| Q4 24 | $83.2M | — | ||
| Q3 24 | $30.1M | — | ||
| Q2 24 | $26.4M | — | ||
| Q1 24 | $27.0M | — |
总债务OFIXPLOW
| Q4 25 | — | $144.0M | ||
| Q3 25 | $157.2M | — | ||
| Q2 25 | $157.0M | — | ||
| Q1 25 | $156.9M | — | ||
| Q4 24 | $157.0M | $147.5M | ||
| Q3 24 | $118.5M | — | ||
| Q2 24 | $118.0M | — | ||
| Q1 24 | $118.2M | — |
股东权益OFIXPLOW
| Q4 25 | $450.0M | $281.4M | ||
| Q3 25 | $442.5M | $275.3M | ||
| Q2 25 | $458.3M | $273.3M | ||
| Q1 25 | $458.3M | $258.9M | ||
| Q4 24 | $503.1M | $264.2M | ||
| Q3 24 | $525.9M | $260.8M | ||
| Q2 24 | $546.0M | $236.7M | ||
| Q1 24 | $570.3M | $217.2M |
总资产OFIXPLOW
| Q4 25 | $850.6M | $626.7M | ||
| Q3 25 | $832.6M | $694.9M | ||
| Q2 25 | $837.2M | $671.5M | ||
| Q1 25 | $823.1M | $621.0M | ||
| Q4 24 | $893.3M | $590.0M | ||
| Q3 24 | $867.9M | $665.6M | ||
| Q2 24 | $882.0M | $617.0M | ||
| Q1 24 | $906.0M | $577.1M |
负债/权益比OFIXPLOW
| Q4 25 | — | 0.51× | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 0.31× | 0.56× | ||
| Q3 24 | 0.23× | — | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $95.9M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $92.8M |
| 自由现金流率自由现金流/营收 | 7.6% | 50.3% |
| 资本支出强度资本支出/营收 | 4.9% | 1.7% |
| 现金转化率经营现金流/净利润 | — | 7.47× |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $63.6M |
8季度趋势，按日历期对齐
经营现金流OFIXPLOW
| Q4 25 | $27.7M | $95.9M | ||
| Q3 25 | $12.4M | $-8.5M | ||
| Q2 25 | $11.6M | $-11.4M | ||
| Q1 25 | $-18.4M | $-1.3M | ||
| Q4 24 | $23.7M | $74.4M | ||
| Q3 24 | $11.7M | $-14.2M | ||
| Q2 24 | $9.0M | $2.5M | ||
| Q1 24 | $-18.6M | $-21.6M |
自由现金流OFIXPLOW
| Q4 25 | $16.8M | $92.8M | ||
| Q3 25 | $2.5M | $-11.4M | ||
| Q2 25 | $4.5M | $-14.3M | ||
| Q1 25 | $-25.1M | $-3.5M | ||
| Q4 24 | $15.2M | $70.2M | ||
| Q3 24 | $6.3M | $-15.2M | ||
| Q2 24 | $-360.0K | $836.0K | ||
| Q1 24 | $-29.1M | $-22.4M |
自由现金流率OFIXPLOW
| Q4 25 | 7.6% | 50.3% | ||
| Q3 25 | 1.2% | -7.1% | ||
| Q2 25 | 2.2% | -7.4% | ||
| Q1 25 | -13.0% | -3.0% | ||
| Q4 24 | 7.0% | 48.9% | ||
| Q3 24 | 3.2% | -11.8% | ||
| Q2 24 | -0.2% | 0.4% | ||
| Q1 24 | -15.4% | -23.4% |
资本支出强度OFIXPLOW
| Q4 25 | 4.9% | 1.7% | ||
| Q3 25 | 4.8% | 1.8% | ||
| Q2 25 | 3.5% | 1.5% | ||
| Q1 25 | 3.5% | 1.9% | ||
| Q4 24 | 4.0% | 2.9% | ||
| Q3 24 | 2.7% | 0.8% | ||
| Q2 24 | 4.7% | 0.8% | ||
| Q1 24 | 5.6% | 0.8% |
现金转化率OFIXPLOW
| Q4 25 | — | 7.47× | ||
| Q3 25 | — | -1.07× | ||
| Q2 25 | — | -0.44× | ||
| Q1 25 | — | -9.03× | ||
| Q4 24 | — | 9.41× | ||
| Q3 24 | — | -0.44× | ||
| Q2 24 | — | 0.10× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
PLOW
| Work Truck Solutions | $101.5M | 55% |
| Transferred At Point In Time | $83.1M | 45% |
